NCT02960763 Optimizing Outcomes of Treatment-Resistant Depression in Older Adults Status COMPLETED Phase PHASE4
NCT02959502 Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression Status ACTIVE_NOT_RECRUITING Phase NA
NCT02959307 Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3) Status COMPLETED Phase NA
NCT02948036 A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety Status COMPLETED Phase NA
NCT02943096 Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression Status TERMINATED Phase NA
NCT02935647 Burst Suppression Anesthesia for Treatment of Severe Depression Status COMPLETED Phase PHASE1
NCT02934035 Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder Status UNKNOWN Phase N/A
NCT02922725 Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females Status TERMINATED Phase PHASE4
NCT02922556 Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD) Status COMPLETED Phase NA
NCT02900092 Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone Status COMPLETED Phase NA
NCT02874131 Behavioral Activation + Cognitive Processing Therapy for PTSD and Comorbid MDD Status COMPLETED Phase NA
NCT02860962 A Trial of Dextromethorphan for Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE1